Systems and methods for disinfection and/or water rinsing of endoscopes in which disinfectant fumes can be contained during use (e.g. to limit operator exposure to disinfectants and fumes).
A topical delivery composition which employs a multivesicular emulsion in combination with a pharmaceuti-cally/pharmacologically active agent is disclosed. The multivesicular emulsion is formed from a quaternary amine salt emulsifier such as behentrimonium methosulfate. The emulsion is multi-lamellar which is a ser...
THE PRESENT INVENTION IS DIRECTED TO TOPICAL ENZYMATIC WOUND DEBRIDING COMPOSITIONS WITH ENHANCED ENZYMATIC ACTIVITY. THESE COMPOSITIONS COMPRISE A DISPERSED PHASE COMPRISING AT LEAST ONE PROTEOLYTIC ENZYME AND AT LEAST ONE HYDROPHILIC POLYOL; AND A CONTINUOUS PHASE COMPRISING A HYDROPHOBIC BASE.
...
The addition of alcohol plus acetate salts unexpectedly enhanced the tuberculocidal activity of glutaraldehyde, and decreased the fumes of glutaraldehyde from the formula of a high-level disinfectant.
An enzymatic wound debrider, comprising: an anhydrous hydrophilic poloxamer carrier, and one or more proteolytic enzymes in an amount effective for wound debridement.
An enzymatic wound debrider composition comprising: an anhydrous hydrophilic poloxamer carrier, and collagenase, wherein the collagenase is present in an amount of from 0.01% to 25% by weight of the composition.
An anhydrous, hydrophilic superabsorbent wound dressing of a viscosity capable of being contained in, and expelled from a dispensing tube, comprising: an anhydrous, hydrophilic gel base carrier selected from the group consisting of poloxamers and polyols; an effective amount of an antimicrobial agent; and a superabs...
Wound debridement compositions containing the proteolytic enzyme Seaprose and use of such compositions in wound treatment for the enzymatic debridement of wounds.
The present invention is directed to topical enzymatic wound debriding compositions with enhanced enzymatic activity. These compositions comprise a dispersed phase comprising at least one proteolytic enzyme and at least one hydrophilic polyol; and a continuous phase comprising a hydrophobic base.
...
[Class : 5] Pharmaceutical Preparations Or The Treatment And Prevention Of Dermatological, Wound, Infection Or Incontinent Conditions Or Diseases, Included In Class 5.
Trade mark is likely to be removed due to non filing of Renewal request within prescribed time limit In case of any discripancy contact respective TM Registry.
Documents
Frm23ACA-170113 for the FY ending on-310312.OCT
FormSchV-170113 for the FY ending on-310312.OCT
Form23AC-170113 for the FY ending on-310312.OCT
Form 23B for period 010411 to 310312-120112.OCT
Fresh Certificate of Incorporation Consequent upon Change of Name on Conversion to Public Limited Company-020112.PDF
Fresh Certificate of Incorporation Consequent upon Change of Name on Conversion to Public Limited Company-020112.PDF
Form23AC-291211 for the FY ending on-310311.OCT
Form 23-020112.PDF
Form 62-020112.PDF
AoA - Articles of Association-020112.PDF
Copy of resolution-020112.PDF
Optional Attachment 1-020112.PDF
Stmnt in lieu of Prospectus-ScheduleIV--020112.PDF
Copy of the agreement-020112.PDF
Form 2-061211.OCT
List of allottees-051211.PDF
Form 32-041111.OCT
Optional Attachment 1-031111.PDF
Acknowledgement of Stamp Duty MoA payment-301210.PDF
Acknowledgement of Stamp Duty AoA payment-301210.PDF